H1N1 (swine flu) & the R&D-based Pharmaceutical Industry

Statement 23 Mar 2026

Sixth meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

On behalf of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), we appreciate the opportunity to contribute to the Sixth Meeting of the Intergovernmental Working Group on the Pandemic Agreement. The innovative pharmaceutical industry is a critical partner in pandemic preparedness and response, through sustained investments in R&D, surveillance, manufacturing capacity, and partnerships that...

Health security for a safer future

This issue brief by Foreign Policy Analytics (FPA), produced with support from IFPMA, examines global health security, highlighting international coordination to strengthen preparedness is vital to protecting lives, economies, and societies from the next major health crisis.

Strengthening global health security: Perspectives from the innovative pharmaceutical industry

IFPMA publication “Strengthening global health security: Perspectives from the innovative pharmaceutical industry”presents the pharmaceutical industry as a central partner in global health security, and capturing the sector’s contributions, key challenges, and concrete policy recommendations.